Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy
Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy have?
Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy has 214 citations in the OpenAlex counts ScholarIQ stores.
When was Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy published?
Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy has 2007 year in the ScholarIQ index.
What is the open-access status of Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy?
Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy has closed oa status in the ScholarIQ index.
What is the DOI of Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy?
The DOI for Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy is on the source record.
What is the PMID of Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy?
The PMID for Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy is on the source record.
What is the OpenAlex record for Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy?
The OpenAlex for Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy is on the source record.